Difference between revisions of "NadB"
Line 93: | Line 93: | ||
* '''Regulation:''' | * '''Regulation:''' | ||
+ | ** repressed in the presence of nicotinic acid ([[NadR]]) [http://www.ncbi.nlm.nih.gov/sites/entrez/16199587 PubMed] | ||
* '''Regulatory mechanism:''' | * '''Regulatory mechanism:''' | ||
+ | ** [[NadR]]: transcription repression [http://www.ncbi.nlm.nih.gov/sites/entrez/16199587 PubMed] | ||
* '''Additional information:''' | * '''Additional information:''' |
Revision as of 16:55, 11 June 2009
- Description: L-aspartate oxidase
Gene name | nadB |
Synonyms | |
Essential | no |
Product | L-aspartate oxidase |
Function | NAD biosynthesis |
MW, pI | 58 kDa, 6.445 |
Gene length, protein length | 1593 bp, 531 aa |
Immediate neighbours | nadC, nifS |
Get the DNA and protein sequences (Barbe et al., 2009) | |
Genetic context This image was kindly provided by SubtiList
|
Contents
The gene
Basic information
- Locus tag: BSU27870
Phenotypes of a mutant
Database entries
- DBTBS entry: [1]
- SubtiList entry: [2]
Additional information
The protein
Basic information/ Evolution
- Catalyzed reaction/ biological activity: L-aspartate + O2 = iminosuccinate + H2O2 (according to Swiss-Prot)
- Protein family: NadB subfamily (according to Swiss-Prot)
- Paralogous protein(s):
Extended information on the protein
- Kinetic information:
- Domains:
- Modification:
- Cofactor(s):
- Effectors of protein activity:
- Interactions:
- Localization:
Database entries
- Structure:
- Swiss prot entry: P38032
- KEGG entry: [3]
- E.C. number: 1.4.3.16
Additional information
Expression and regulation
- Operon:
- Additional information:
Biological materials
- Mutant:
- Expression vector:
- lacZ fusion:
- GFP fusion:
- two-hybrid system:
- Antibody:
Labs working on this gene/protein
Alessandra Albertini, University of Pavia, Italy homepage
Your additional remarks
References
- Author1, Author2 & Author3 (year) Title Journal volume: page-page. PubMed